Employees: 01 (2023.0)Legal category: Société à responsabilité limitée (sans autre indication)Size: PMECreation date: 2006-06-01 (19 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: GUINGAMP (22200), Cotes-d'Armor
PHARMACIE DE LA PLOMEE : revenue, balance sheet and financial ratios
PHARMACIE DE LA PLOMEE is a French company
founded 19 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in GUINGAMP (22200),
this company of category PME
shows in 2023 a revenue of 652 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE DE LA PLOMEE (SIREN 490312063)
Indicator
2025
2024
2023
2022
2021
2020
2017
Revenue
N/C
N/C
652 259 €
716 882 €
729 318 €
N/C
N/C
Net income
62 272 €
-240 931 €
41 325 €
67 498 €
52 847 €
51 440 €
-134 381 €
EBITDA
N/C
N/C
61 513 €
97 192 €
74 991 €
N/C
N/C
Net margin
N/C
N/C
6.3%
9.4%
7.2%
N/C
N/C
Revenue and income statement
In 2025, PHARMACIE DE LA PLOMEE generates positive net income of 62 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
62 272 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 88%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 46%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
88.321%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
46.467%
Asset age ratio (2025)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution PHARMACIE DE LA PLOMEE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2020
2021
2022
2023
2024
2025
Debt ratio
687.059
192.764
131.976
89.117
71.566
174.221
88.321
Financial autonomy
11.084
31.206
38.875
47.857
53.013
31.724
46.467
Repayment capacity
None
None
6.324
4.359
5.688
None
None
Cash flow / Revenue
None%
None%
7.44%
9.362%
6.661%
None%
None%
Sector positioning
Debt ratio
88.322025
2023
2024
2025
Q1: 13.57
Med: 49.47
Q3: 128.28
Average+11 pts over 3 years
In 2025, the debt ratio of PHARMACIE DE LA PLOMEE (88.32) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
46.47%2025
2023
2024
2025
Q1: 33.69%
Med: 53.88%
Q3: 72.26%
Average-15 pts over 3 years
In 2025, the financial autonomy of PHARMACIE DE LA PLOMEE (46.5%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Repayment capacity
5.69 years2023
2023
Q1: 0.95 years
Med: 3.58 years
Q3: 7.48 years
Average
In 2023, the repayment capacity of PHARMACIE DE LA PLOMEE (5.69) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 65.96. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
65.963
Liquidity indicators evolution PHARMACIE DE LA PLOMEE
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2017
2020
2021
2022
2023
2024
2025
Liquidity ratio
52.018
64.222
64.302
87.654
79.503
61.191
65.963
Interest coverage
None
None
15.338
10.282
15.104
None
None
Sector positioning
Liquidity ratio
65.962025
2023
2024
2025
Q1: 131.48
Med: 182.6
Q3: 258.72
Watch
In 2025, the liquidity ratio of PHARMACIE DE LA PLOMEE (65.96) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.
Interest coverage
15.1x2023
2023
Q1: 0.38x
Med: 2.71x
Q3: 6.47x
Excellent
In 2023, the interest coverage of PHARMACIE DE LA PLOMEE (15.1x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2025)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2025)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2025)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2025)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE DE LA PLOMEE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2020
2021
2022
2023
2024
2025
Operating WCR
0 €
0 €
38 544 €
47 286 €
70 627 €
0 €
0 €
Inventory turnover (days)
0
0
18
19
21
0
0
Customer payment term (days)
0
0
5
7
9
0
0
Supplier payment term (days)
0
0
33
36
44
0
0
Positioning of PHARMACIE DE LA PLOMEE in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 277 transactions of similar company sales
in 2025,
the value of PHARMACIE DE LA PLOMEE is estimated at
989 198 €
(range 671 274€ - 1 552 188€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2025
277 transactions
671k€989k€1552k€
989 198 €Range: 671 274€ - 1 552 188€
NAF 5 année 2025
Valuation method used
Net Income Multiple
62 272 €
×
15.9x
=989 198 €
Range: 671 275€ - 1 552 188€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE DE LA PLOMEE with other companies in the same sector:
Frequently asked questions about PHARMACIE DE LA PLOMEE
What is the revenue of PHARMACIE DE LA PLOMEE ?
The revenue of PHARMACIE DE LA PLOMEE in 2023 is 652 k€.
Is PHARMACIE DE LA PLOMEE profitable?
Yes, PHARMACIE DE LA PLOMEE generated a net profit of 62 k€ in 2025.
Where is the headquarters of PHARMACIE DE LA PLOMEE ?
The headquarters of PHARMACIE DE LA PLOMEE is located in GUINGAMP (22200), in the department Cotes-d'Armor.
Where to find the tax return of PHARMACIE DE LA PLOMEE ?
The tax return of PHARMACIE DE LA PLOMEE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE DE LA PLOMEE operate?
PHARMACIE DE LA PLOMEE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart